CoMIT pamphlet 2025
34/44

Responsible DepartmentResearch PartnerResponsible DepartmentResearch Partner33337F8F 0813B0702We are developing innovative software that leverages ophthalmic imaging data to tackle challenging diagnostic and therapeutic issues in eye diseases. By integrating the outcomes of diagnosis, treatment, and follow-up evaluations, we will enhance our equipment’s functionality in conjunction with expert clinical assessments. Furthermore, we are partnering with health screening centers to merge data from ophthalmological instruments with general health screening results. This approach helps us trace the progression from healthy states to the onset of diseases, enhancing our understanding and management of both eye and systemic diseases. Looking ahead, we will use this comprehensive data to refine our software further, and develop diagnostic tools and clinical metrics that will inform more effective treatment plans.Based on highly sensitive and precision spectroscopic measurement technology, we aim to develop new diagnostic and testing technologies for maintaining people's health, providing gentler medical care and a drug discovery environment. Photonics measurement technology enables non-invasive and multiple informative measurement. For example, non-invasive analysis for iPS-derived cells and organoids is possible, and it is expected to support stable production and quality evaluation of them, and contributes to drug discovery and regenerative medicine. In addition, we can expect to contribute to medical care and health by evolving highly sensitive measurement at the molecular level and integration technology of analytical functions into microfluidic chips, and developing highly sensitive and low-cost nucleic acid testing device. In order to utilize these technologies as precise and easy diagnostic methods in the medical field, we will promote field-integrated research through an industry-government-academia collaboration system. School of Medicine and hospital in The University of Osaka will play a central role in collaborating with companies and Life and Medical Photonics Division in OTRI.A-33C-9Department of Vision Informatics Graduate School of EngineeringDepartment of OphthalmologyDepartment of NeurosurgeryMARUYAMA KazuichiSpecially Appointed Associate ProfessorFUJITA KatsumasaProfessorNISHIDA KohjiProfessorKISHIMA HaruhikoProfessorDepartment ofVision InformaticsTOPCON CORPORATIONDepartment of NeurosurgerySysmex CorporationThe Center of Medical Innovation and Translational ResearchResearch and Development Department Research and development of precision diagnostics by highly sensitive spectroscopy(Life and Medical Photonics Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI))Exploration of Innovative Diagnostic and Therapeutic Approaches for Ocular Diseases1. Development of advanced diagnostic imaging software2. Creation of diagnostic equipment and clinical indices that enhance decision-making in the diagnosis and treatment of both ophthalmic and systemic diseases

元のページ  ../index.html#34

このブックを見る